Beneficial effects of weight loss in overweight patients with chronic proteinuric nephropathies

被引:258
作者
Morales, E
Valero, MA
León, M
Hernández, E
Praga, M
机构
[1] Hosp Univ 12 Octubre, Dept Nephrol, Madrid, Spain
[2] Hosp Univ 12 Octubre, Dept Endocrinol, Madrid, Spain
关键词
weight loss; proteinuria decrease; overweight; low-calorie diet; type; 2; diabetes;
D O I
10.1053/ajkd.2003.50039
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background Proteinuria is a recognized complication of obesity, but no study has investigated the effect of weight loss in overweight patients with chronic proteinuric nephropathies of different causes. Methods: We randomly assigned (in a 2:1 ratio) 30 overweight patients (body mass index [BMI] > 27 kg/m(2)) with diabetic and nondiabetic proteinuric nephropathies to either follow a low-calorie normoproteinic diet or maintain their usual dietary intake for 5 months. The primary outcome was change in urinary protein excretion. Secondary outcomes were changes in renal function (serum creatinine level and Cockcroft-Gault creatinine clearance) and lipid profile. Results: Patients in the diet group showed a significant decrease in body weight and BMI, whereas patients in the control group showed a significant increase in body weight and BMI (between-group comparison, P < 0.05). Mean weight loss in the diet group was 4.1% +/- 3%, and 14 of 20 patients in this group lost more than 3%. Proteinuria decreased by 31.2% +/- 37% in the diet group (from protein of 2.8 +/- 1.4 to 1.9 +/- 1.4 g/24 h; P < 0.005), whereas it tended to increase in the control group (between-group comparison, P < 0.05). Changes in renal function did not differ significantly between groups, although renal function remained stable in the diet group and showed significant worsening in the control group. Serum triglyceride levels remained stable in the diet group and tended to increase in the control group (between-group comparison, P < 0.05). Conclusion: Moderate weight loss in overweight patients with chronic proteinuric nephropathies induces a significant decrease in proteinuria.
引用
收藏
页码:319 / 327
页数:9
相关论文
共 33 条
[1]   Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy [J].
Brenner, BM ;
Cooper, ME ;
de Zeeuw, D ;
Keane, WF ;
Mitch, WE ;
Parving, HH ;
Remuzzi, G ;
Snapinn, SM ;
Zhang, ZX ;
Shahinfar, S .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (12) :861-869
[2]   Glomerular hemodynamics in severe obesity [J].
Chagnac, A ;
Weinstein, T ;
Korzets, A ;
Ramadan, E ;
Hirsch, J ;
Gafter, U .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2000, 278 (05) :F817-F822
[3]   PREDICTION OF CREATININE CLEARANCE FROM SERUM CREATININE [J].
COCKCROFT, DW ;
GAULT, MH .
NEPHRON, 1976, 16 (01) :31-41
[4]   Insulin resistance, elevated glomerular filtration fraction, and renal injury [J].
Dengel, DR ;
Goldberg, AP ;
Mayuga, RS ;
Kairis, GM ;
Weir, MR .
HYPERTENSION, 1996, 28 (01) :127-132
[5]   Effect of lipid reduction on the progression of renal disease: A meta-analysis [J].
Fried, LF ;
Orchard, TJ ;
Kasiske, BL .
KIDNEY INTERNATIONAL, 2001, 59 (01) :260-269
[6]  
GANSEVOORT RT, 1995, NEPHROL DIAL TRANSPL, V10, P1963
[7]   Abnormal kidney function as a cause and a consequence of obesity hypertension [J].
Hall, JE ;
Brands, MW ;
Henegar, JR ;
Shek, EW .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1998, 25 (01) :58-64
[8]  
Harris JA, 1919, PUBLICATION CARNEGIE, V279
[9]   Renoprotection: One or many therapies? [J].
Hebert, LA ;
Wilmer, WA ;
Falkenhain, ME ;
Ladson-Wofford, SE ;
Nahman, NS ;
Rovin, BH .
KIDNEY INTERNATIONAL, 2001, 59 (04) :1211-1226
[10]   Proximal tubular epithelial hyperplasia in patients with chronic glomerular proteinuria [J].
Hebert, LA ;
Agarwal, G ;
Sedmak, DD ;
Mahan, JD ;
Becker, W ;
Nagaraja, HN .
KIDNEY INTERNATIONAL, 2000, 57 (05) :1962-1967